Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
generic glp-1 agonists obesity #diabetes #biosimilar #generic #biotechindustry #pharma | Maryam Daneshpour, PhD, MBA Best-selling Booklist – USA Quantity:30 CT (1 Bottle) category=bestsellers
Best-selling Booklist – USA TODAY
As we look to 2026, the story becomes one of defining firsts: the debut of oral GLP-1s, the first loss of exclusivity for a GLP-1 receptor antagonist, and landmark coverage decisions such as obesity medications entering Medicare formularies for obesity as a standalone indication
category=bestsellers
Quantity:30 CT (1 Bottle)
The retrospective study looked at patients on GLP-1s from five to 10 years ago and then followed them
US$ 28.70
US$ 26.88
US$ 20.31
US$ 26.41
